Novel Fluorophore Helps Reduce Surgical Risk in Patients Undergoing Prostatectomy

Novel Fluorophore Helps Reduce Surgical Risk in Patients Undergoing Prostatectomy

From Surgical Readings by The American College of Surgeons

February 4, 2026 · 18 min · Episode 23

About this episode

This episode discusses the use of a novel fluorophore to illuminate nerve structures during robotic-assisted prostatectomy, potentially revolutionizing prostatic surgery.

In this episode, host Rick Greene, MD, FACS, talks with Samuel A. Gold, MD, from the urology service in the Department of Surgery at Memorial Sloan Cancer Center in New York, New York, about using intraoperative fluorescence to illuminate nerve structures during robotic-assisted prostatectomy. Dr. Gold’s phase-1 study, published in JAMA Surgery (Rizedisben in Minimally Invasive Surgery), found that the fluorophore was generally well tolerated and clinically effective, which could revolutionize prostatic surgery and lead to wider applicability. Talk about the podcast on social media using the hashtag #SurgicalReadings

People in this episode

Host: Rick Greene, MD, FACS

Guest: Samuel A. Gold, MD

Topics covered

  • surgery
  • prostatectomy
  • fluorescence
  • robotic-assisted surgery
  • nerve structures
  • clinical study

Keywords

  • fluorophore
  • surgical risk
  • prostatectomy
  • intraoperative fluorescence
  • robotic surgery
  • clinical effectiveness
  • nerve illumination

Mentioned in this episode

Organizations: Memorial Sloan Cancer Center, JAMA Surgery

Books & works: Rizedisben in Minimally Invasive Surgery

More episodes of Surgical Readings

Explore listener stats, chart rankings, contacts and more on the Surgical Readings podcast page.